Menu Close

Articles on COVID-19 vaccines

Displaying 1 - 20 of 164 articles

Colorized scanning electron micrograph of a cell (orange) infected with UK B.1.1.7 variant SARS-CoV-2 virus particles (green), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. (NIAID)

COVID-19 variants FAQ: How did the U.K., South Africa and Brazil variants emerge? Are they more contagious? How does a virus mutate? Could there be a super-variant that evades vaccines?

Variants of the original SARS-CoV-2 are now in wide circulation. That means the third wave of COVID-19 has come with new questions about the variants, their effects and what might come next.
The AstraZeneca vaccine was 70 per cent effective against symptomatic COVID-19 infection in a large multinational study, and recently reported 76 per cent overall efficacy against symptomatic COVID-19 in another large study done primarily in the United States. THE CANADIAN PRESS/John Woods

AstraZeneca COVID-19 vaccine FAQ: Why do the age recommendations keep changing? Does it cause VIPIT blood clots? Is it effective against variants?

With changing recommendations about AstraZeneca's COVID-19 vaccine making headlines, many people have questions about its use.
See, no crying or big needles, just a person of colour showing off his plaster. This image does the job without scaring people and demonstrates diversity. from www.shutterstock.com

Pictures of COVID injections can scare the pants off people with needle phobias. Use these instead

Our well-meaning efforts to use images to help demystify the vaccination process or share our pride in getting a COVID vaccine can backfire.
A sign shows the way to a recovery area to monitor any immediate side effects from the COVID-19 vaccine on Dec. 17, 2020, in Reno, Nevada. Patrick T. Fallon /AFP via Getty Images

What COVID-19 vaccine side effects might I expect?

Many people never experience the least bit of discomfort from the COVID-19 vaccines, but mild side effects are common. They include swelling in the affected arm, nausea and chills.
Workers at India’s biggest syringe manufacturer ramp up production in September 2020 in race to meet COVID-19 vaccine-driven demand. Photo by SAJJAD HUSSAIN/AFP via Getty Images

Why India is banking on health diplomacy to grow African footprint

There are three broad sets of health-related opportunities and benefits that may shape the future of India-Africa relations.

Top contributors

More